Bharadwaj Jagannathan

Title: Bharadwaj Jagannathan: Innovator in Pharmaceutical Composition

Introduction

Bharadwaj Jagannathan is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance the storage and administration of bispecific antibody constructs.

Latest Patents

Jagannathan holds a patent for a pharmaceutical composition comprising bispecific antibody constructs for improved storage and administration. This invention provides an improved pharmaceutical composition that includes a bispecific antibody construct, a preservative, and a diluent. The bispecific antibody construct is designed to be stable and recoverable, with a concentration ranging from about 0.5 μg/ml to 20 mg/ml. This advancement is crucial for ensuring the efficacy and safety of pharmaceutical products.

Career Highlights

Throughout his career, Bharadwaj Jagannathan has worked with prominent companies in the biotechnology sector, including Amgen Inc. and Amgen Research GmbH. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Jagannathan has collaborated with esteemed colleagues such as Jeff Abel and Lingwen Cui. These partnerships have fostered innovation and have been instrumental in the advancement of his research endeavors.

Conclusion

Bharadwaj Jagannathan is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the field. His innovative approach to bispecific antibody constructs exemplifies the importance of research and development in improving healthcare solutions.